Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

Krynyckyi, Borys R.; Shim, Jungho; Lim, Ilhan

doi:10.1002/cncr.11946

Cited by 2 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two studies by Rietman et al [12,17], were initially excluded in this constrained comparison because the use of lymphoscintigraphy was unclear [12,17,30-32] and portions of the data in the initial earlier study were in error [12,31,33]. In addition, there are suggestions that a dissection intensive blue dye technique was used as the main method of finding the SN over a more targeted radiotracer/probe method, which appeared to only have a secondary role in finding the SN [12,17,30-32].…”

Section: Methodsmentioning

confidence: 99%

“…In addition, there are suggestions that a dissection intensive blue dye technique was used as the main method of finding the SN over a more targeted radiotracer/probe method, which appeared to only have a secondary role in finding the SN [12,17,30-32]. These two studies [12,17] were based on the exact same population of patients but at different time points of morbidity assessment.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature

Kim

Moadel

et al. 2005

World J Surg Onc

View full text Add to dashboard Cite

Because of variations in techniques and time of assessing morbidity, direct comparisons between studies are difficult. Nevertheless at a minimum, a clear trend is present: having the LS images and skin markings to assist during SLNB appears to yield more favorable morbidity outcomes for the patients compared to performing SLNB with only the probe or performing SLNB with dye alone. These results are extremely pertinent, as the main reason for performing SLNB itself in the first place is to achieve reduced morbidity.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature

Kim

Moadel

et al. 2005

World J Surg Onc

View full text Add to dashboard Cite

show abstract

Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

Krynyckyi

Kim

2004

Cancer

Self Cite

View full text Add to dashboard Cite

W e congratulate Denny et al. 1 for their report on direct visual inspection for cervical carcinoma screening. However, we question their recommendation to link visual inspection with immediate ablative treatment, an experimental strategy that they refer to as 'screen and treat'.Because poor-quality cervical screening programs can do more harm than good, and because entropy is real, cervical screening programs require routine audits. [2][3][4] Definitions of harm and good will vary among different communities, but the requirement for audit is universal to assess that screening programs remain in compliance with community standards. The screen-and-treat algorithm, outside of controlled research settings, produces no physical evidence on which to base meaningful program audits.Proponents of this algorithm, when challenged, have failed to provide solutions to the quality-control paradox embedded in that screening algorithm. 5,6 Therefore, it appears that the screen-and-treat protocol is not compatible with the requirements of 'first do no harm.' Consequently, this protocol has been characterized as an inappropriate public health policy. 7 We ask Denny et al. 1 to justify their continued support of the screenand-treat algorithm in the face of the concerns described above.

show abstract

Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

Cited by 2 publications

References 7 publications

Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature

Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: A review of the literature

Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

Contact Info

Product

Resources

About